Abstract
The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).
Originalsprog | Engelsk |
---|---|
Tidsskrift | National Cancer Institute. Journal (Online) |
Vol/bind | 102 |
Udgave nummer | 5 |
Sider (fra-til) | 325-39 |
Antal sider | 15 |
ISSN | 1460-2105 |
DOI | |
Status | Udgivet - 3 mar. 2010 |